News Home

Where Does Wall Street Think Unity Biotechnology Inc (UBX) Stock Will Go?

Wednesday, February 17, 2021 01:30 PM | InvestorsObserver Analysts
Where Does Wall Street Think Unity Biotechnology Inc (UBX) Stock Will Go?

Analysts who follow Unity Biotechnology Inc (UBX) on average expect it to decline -22.28% over the next twelve months. Those same analysts give the stock an average rating of Buy.

That average rating earns Unity Biotechnology Inc an Analyst Ranking of 18, which means it ranks higher than 18 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 3.4
Wall Street analysts are rating UBX a Buy today. Find out what this means to you and get the rest of the rankings on UBX!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.

InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Unity Biotechnology Inc Stock Today?

Unity Biotechnology Inc (UBX) stock is trading at $7.72 as of 1:22 PM on Wednesday, Feb 17, a decline of -$0.70, or -8.32% from the previous closing price of $8.42. The stock has traded between $7.40 and $8.20 so far today. Volume today is 937,067 compared to average volume of 1,052,577.

Click Here to get the full report on Unity Biotechnology Inc (UBX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App